Ultrafiltration Drug Release Assay Utilizing a Stable Isotope Tracer
| Standard Number | PHA-2 |
|---|---|
| Organization |
Nanotechnology Characterization Laboratory
|
| Level | National |
| Category | Test Method | Characterization | Measurement |
| Status |
|
ABSTRACT
This protocol is written to conduct an in vitro drug release study in human plasma, comparing drug release of a bilayer-loaded docetaxel (DTX) nanoliposome to the commercial DTX formulation, Taxotere®, and solvent solubilized DTX.